Has Dipen Patel, MD received payments from drug or device companies?

Yes. Drug and device makers reported $287 in general payments to Dipen Patel, MD across 3 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Dipen Patel, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Dipen Patel, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Dipen Patel, MD

Hematology & Oncology · Smithtown, NYNPI 1831552124

Payments from drug & device makers

$287in general payments, 2019–2025

Across 3 payments — averaging $95.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Sanofi$287

What the payments were for

Food & beverage$287100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Sanofi	3	$287

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

SARCLISA$129

How this compares

$287 in reported general payments places this provider in the 20th percentile of 967 hematology & oncology providers in New York.

See all hematology & oncology providers in New York →

Medicare billing

Part B allowed, 2024

$2,568,092

Medicare patients

2,313

Services billed

213,098

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
AranespDarbepoetin Alfa In Polysorbat	82	$245,175
KeytrudaPembrolizumab	11	$126,253
Somatuline DepotLanreotide Acetate	13	$109,936
Abiraterone Acetate	25	$109,176
Lupron DepotLeuprolide Acetate	14	$79,630
Neulasta OnproPegfilgrastim	12	$75,086
EliquisApixaban	43	$53,719
Deferasirox	12	$45,816
Gammagard LiquidImmun Glob G(Igg)/Gly/Iga Ov50	12	$26,036
AkynzeoFosnetupitant/Palonosetron	16	$17,384
Palonosetron Hcl	13	$587
Prednisone	26	$515
Ondansetron OdtOndansetron	12	$203
Warfarin Sodium	13	$39

Paid to pharmacies, not to this prescriber.

Other hematology & oncology in Smithtown

Vicky MakkerNew York$27.1M
Alison MoskowitzNew York$22.7M
Ajai ChariNew York$22.4M
Yelena JanjigianNew York$16.9M
Alexander LesokhinNew York$11.9M
John MascarenhasNew York$11.8M
Maria PalombaNew York$11.6M
Richard ZunigaBabylon$10.9M
Scott TagawaNew York$10.3M
Mohammad Abdul HayNew York$9.9M

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →